Back to discover
Disease

Food Hypersensitivity

Active therapeutic pipelineEmerging researchRising momentum
MeSHFood Hypersensitivity
4
Publications
8
Clinical trials
2024
Latest publication
Current focus
Therapeutic developmentInflammation & immunityMetabolic & lifestyle factors
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 1 clinical trial expected to report results, the earliest in Q2 2027.
Upcoming Milestones
Major developments
Upcoming trial readoutHigh impact
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
Results expected Q2 20272026-06-08
Clinical Milestones1View
Results expected 1
Activity timeline1

Clinical trials

3 sponsors · 0 new · 0 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
8
All trials
1
Active
0
Late-stage
6
Completed
Recruiting

Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

Phase 2 · Recruiting · Johns Hopkins University
Recently completed

Determining the Efficacy and Value of Immunotherapy on the Likelihood of Peanut Tolerance: The DEVIL Study; Grant "Optimizing Tolerance Induction in Peanut Allergy: The DEVIL Study"

Phase 2 · Completed · University of North Carolina, Chapel Hill

A Double-blinded, Placebo-controlled Study of Peanut Sublingual Immunotherapy in Children - DBPC Peanut SLIT

Phase 2 · Completed · University of North Carolina, Chapel Hill

Mechanisms of Desensitization During Peanut Oral Immunotherapy

Phase 2 · Completed · University of North Carolina, Chapel Hill

Dietary Intervention in Milk Allergy and Tolerance Development

Phase 2 · Completed · National Institute of Allergy and Infectious Diseases (NIAID)

Oral Immunotherapy for Peanut Allergy (2nd Generation PMIT Collaboration With Arkansas Children's)

Phase 2 · Completed · University of North Carolina, Chapel Hill

Sublingual Immunotherapy for Peanut Allergy: A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Pilot Study With a Whole Peanut Extract

Phase 1/2 · Completed · National Institute of Allergy and Infectious Diseases (NIAID)

Research activity

4 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20222024
Major themes6
  • Food Hypersensitivity4
  • Exposome1
  • Gastrointestinal Microbiome1
  • Immunity, Innate1
  • Immunoglobulin E1
  • Microbiota1
Leading journals4
  • Allergy1
  • European journal of immunology1
  • Nutrients1
  • Trends in biotechnology1
Leading researchers8
  • Akdis CA1
  • Akdis M1
  • Altiner S1
  • Bastiaan-Net S1
  • Cammarota G1
  • Caruso C1
  • Celebi Sozener Z1
  • Cerci P1
Affiliations (unnormalised)6
  • Airway Research Center North1
  • Ankara University1
  • Center for Basic and Clinical Immunology Research (CISI)1
  • Center of Excellence1
  • Christine Kühne-Center for Allergy Research and Education (CK-CARE)1
  • Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens in food.

Identifiers
MeSHFood Hypersensitivity
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.